Contents
2.In addition to the participants listed in paragraph 1, where the joint scientific consultation is carried out in parallel with the expert panel consultation, the following participants shall be invited to the meeting as referred to in Article 18(8) of Regulation (EU) 2021/2282:
(a)the advisors of the expert panel involved in the expert panel consultation;
(b)the staff members of the European Medicines Agency providing secretariat support to the expert panel.
On request from the European Medicines Agency, patients selected in accordance with the relevant rules of the European Medicines Agency to participate during the consultation with the expert panels may be invited to the meeting for an exchange of views.On request from the health technology developer, representatives from the notified body chosen by the health technology developer may be invited to the meeting for an exchange of views as observers.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.